ADVM
Adverum Biotechnologies
ADVM
ADVM
Delisted
ADVM was delisted on the 8th of December, 2025.
50 hedge funds and large institutions have $63.8M invested in Adverum Biotechnologies in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
35% less call options, than puts
Call options by funds: $196K | Put options by funds: $301K
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
70% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 23
Holders
50
Holding in Top 10
4
Calls
$196K
Puts
$301K
Top Buyers
| 1 | +$2.97M | |
| 2 | +$206K | |
| 3 | +$144K | |
| 4 |
Two Sigma Advisers
New York
|
+$80.7K |
| 5 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
+$37.8K |
Top Sellers
| 1 | -$611K | |
| 2 | -$378K | |
| 3 | -$304K | |
| 4 |
Goldman Sachs
New York
|
-$279K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$180K |
